Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
1993 3
1994 7
1995 4
1996 11
1997 8
1998 12
1999 15
2000 7
2001 12
2002 21
2003 28
2004 23
2005 36
2006 28
2007 31
2008 29
2009 28
2010 37
2011 45
2012 58
2013 53
2014 53
2015 50
2016 40
2017 36
2018 45
2019 49
2020 32
2021 34
2022 32
2023 28
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

798 results

Results by year

Filters applied: . Clear all
Page 1
Polypharmacy in Patients with Chronic Kidney Disease.
Oosting IJ, Colombijn JMT, Kaasenbrood L, Liabeuf S, Laville SM, Hooft L, Bots ML, Verhaar MC, Vernooij RWM. Oosting IJ, et al. Among authors: bots ml. Kidney360. 2024 Apr 25. doi: 10.34067/KID.0000000000000447. Online ahead of print. Kidney360. 2024. PMID: 38661553 Free article.
Rationale and design for the randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty (CLEAR-PATH).
Wegerif ECJ, Ünlü Ç, Generaal MI, van den Bor R, van de Ven PM, Bots ML, de Borst GJ. Wegerif ECJ, et al. Among authors: bots ml. Am Heart J. 2024 Apr 10:S0002-8703(24)00080-2. doi: 10.1016/j.ahj.2024.04.001. Online ahead of print. Am Heart J. 2024. PMID: 38608997 Free article.
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.
Helmink MAG, Peters SAE, Westerink J, Harris K, Tillmann T, Woodward M, van Sloten TT, van der Meer MG, Teraa M, Dorresteijn JAN, Ruigrok YM, Visseren FLJ, Hageman SHJ; UCC-SMART study group. Helmink MAG, et al. Eur J Prev Cardiol. 2024 Apr 8:zwae096. doi: 10.1093/eurjpc/zwae096. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 38584392
Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic Review.
Colombijn JMT, Idema DL, van Beem S, Blokland AM, van der Braak K, Handoko ML, In 't Veld LFH, Kaul T, Kolagasigil-Akdemir N, Kusters MPT, Meijvis SCA, Oosting IJ, Spijker R, Bots ML, Hooft L, Verhaar MC, Vernooij RWM. Colombijn JMT, et al. Among authors: bots ml. JAMA Netw Open. 2024 Mar 4;7(3):e240427. doi: 10.1001/jamanetworkopen.2024.0427. JAMA Netw Open. 2024. PMID: 38451526 Free PMC article.
Determination of the clinical relevance of donor epitope-specific HLA-antibodies in kidney transplantation.
Kardol-Hoefnagel T, Senejohnny DM, Kamburova EG, Wisse BW, Reteig L, Gruijters ML, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Roelen DL, Claas FH, Bemelman FJ, Senev A, Naesens M, Heidt S, Otten HG. Kardol-Hoefnagel T, et al. Among authors: bots ml. HLA. 2024 Jan;103(1):e15346. doi: 10.1111/tan.15346. HLA. 2024. PMID: 38239046
798 results